10X Genomics

Forecast & Rating17 analysts currently cover 10X Genomics, with about 35.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $51.00, about 18.6% downside from the current price of $62.65. Price targets range from $40.00 to $70.00 — a wide spread, showing clear disagreement over just how much 10X Genomics can rise. Historically, about 48.6% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on 10X Genomics's outlook. Data as of Sep 3, 2026; for reference only and not investment advice.